Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1978-11-13
1979-12-18
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
128260, 424 14, 424 16, 424 19, 424 35, 424362, A61K 922, A61K 926
Patent
active
041794974
ABSTRACT:
Solid unit dosage medicaments which are suitable for use in animals and humans are prepared with hydroxypropyl cellulose as the primary formulating excipient. These medicaments are particularly suitable for ophthalmic use since they are slowly but completely water soluble when they are inserted in the cul-de-sac of the eye and thus provide for a convenient means of prolonged treatment of the eye with concomitant reduced dosing frequency.
REFERENCES:
patent: 108034 (1870-10-01), Kraus
patent: 273410 (1883-03-01), Wadleigh
patent: 1872826 (1932-08-01), Schulemann et al.
patent: 2397903 (1946-04-01), Puetzer
patent: 3278521 (1966-10-01), Klug
patent: 3424842 (1969-01-01), Nurnberg
patent: 3450814 (1969-06-01), Bechtold et al.
patent: 3776001 (1973-12-01), Hanke et al.
patent: 3845201 (1974-10-01), Haddad et al.
patent: 3852421 (1974-12-01), Kuyanagi et al.
patent: 3863633 (1975-02-01), Ryde et al.
patent: 3867519 (1975-02-01), Michaels
patent: 3868445 (1975-02-01), Ryde et al.
patent: 3870791 (1975-03-01), Haddad et al.
patent: 3875300 (1975-04-01), Homm et al.
patent: 3981303 (1976-09-01), Higuchi et al.
patent: 3986510 (1976-10-01), Higuchi et al.
patent: 3993071 (1976-11-01), Higuchi et al.
patent: 4001388 (1977-01-01), Shell
Hercules, Inc., "Fact Sheet on Klucel", 2 pp., Dec. 4, 1972.
Hercules, Inc., "Klucel Hydroxypropyl Cellulose", 32 pp., (1971).
Klug, J. Polymer Sci., Part C, No. 36:491-508 (1971), "Some Properties of Water-Soluble Hydroxyalkyl Celluloses and Their Derivatives".
Lemp et al., Ann. Ophthalmol. 4(1):15-20, (1972), "Ophthalmic Polymers as Ocular Wetting Agents".
Lemp, "Artificial Tear Solutions", Int. Ophthal. Clin. 13(1):221-228 (1973).
U.S.P.T.O. Translation, (22 p.), 10/17/78, (P.C.C.), of Saias et al., Ann. Pharm. Fr., 27:557-570 (1969), The Pamoates: A Class of Oral and Prolonged Action Drugs.
Anon, Chem. Abstr. 14, #3501.sup.6 (1920), of Rep. Lab. Am. Med. Ass., 12:96-97 (1919), "The Relative Permancy in Moist Air of Pilocarpine Hydrochloride and Pilocarpine Nitrate".
Loucas et al., J. Pharm. Sci., 61(6):985-986, Jun. 1972, "Solid State Ophthalmic Dosage Systems".
British Pharmacopoeia (1953), Pharmaceutical Press, London (1953), pp. 59, 60, 155, 263, 300, 428, 876.
"P.F.", vol. I, Pharmaceutical Formulas, 10th Ed. Chemist and Druggist, London, (1946), pp. 279-280, 977, 1117.
Prosser, James, A Guide to the New Pharmacopoeia, 2nd Ed. Churchill, London (1885), pp. 7, 66-69, 72-75, 94-95, 110-111, 116.
Cohen Edward M.
Grim Wayne M.
Harwood Richard J.
Mehta Gunvant N.
Merck & Co. , Inc.
Monaco Mario A.
Riedl Edmunde D.
Rose Shep K.
LandOfFree
Solid state ophthalmic medication does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid state ophthalmic medication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid state ophthalmic medication will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-453574